Clinical trial

Efficacy and Safety of Glucosanol™ in Body Weight Reduction

NCT02930668

Study summary

ClinicalTrials.gov

Efficacy and Safety of Glucosanol™ in Body Weight Reduction

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention Glucosanol 350mg Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Glucosanol 500mg Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-05-01

PhaseNA

Conditions

Overweight and Obesityunresolved

Interventions

Glucosanol 350mgDIETARY_SUPPLEMENT

Glucosanol 500mgDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

InQpharm Grouplead sponsor

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02930668 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.